These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18505898)

  • 1. Pancreatic cancer.
    Gyllenhaal C; Alschuler L; Rubin D; Kranz S; Roddy GD; Block KI
    Integr Cancer Ther; 2008 Jun; 7(2):103-13. PubMed ID: 18505898
    [No Abstract]   [Full Text] [Related]  

  • 2. Neoadjuvant chemoradiation to convert locally advanced pancreatic body adenocarcinoma to resectable disease.
    Cunningham SC; Cusnir M; Burdick RK; Van Echo DA; Moesinger R
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):741-2; discussion 743. PubMed ID: 16258479
    [No Abstract]   [Full Text] [Related]  

  • 3. Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study.
    Javle M; Yu J; Garrett C; Pande A; Kuvshinoff B; Litwin A; Phelan J; Gibbs J; Iyer R
    Br J Cancer; 2009 Jun; 100(12):1842-5. PubMed ID: 19491904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic cancer: an update.
    Kindler HL
    Curr Oncol Rep; 2007 May; 9(3):170-6. PubMed ID: 17430687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer.
    Kulke MH; Blaszkowsky LS; Ryan DP; Clark JW; Meyerhardt JA; Zhu AX; Enzinger PC; Kwak EL; Muzikansky A; Lawrence C; Fuchs CS
    J Clin Oncol; 2007 Oct; 25(30):4787-92. PubMed ID: 17947726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locally advanced unresectable pancreatic cancer.
    Johung KL; Saif MW; Chang BW
    JOP; 2014 Jul; 15(4):329-31. PubMed ID: 25076335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erlotinib or capecitabine with gemcitabine in pancreatic cancer?
    de Jager J; Stebbing J
    Future Oncol; 2006 Apr; 2(2):161-3. PubMed ID: 16563084
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer.
    Kim JS; Lim JH; Kim JH; Im SA; Chie EK; Hwang JH; Kim TY; Bang YJ; Ha SW; Yoon YB
    Cancer Chemother Pharmacol; 2012 Sep; 70(3):381-9. PubMed ID: 22806305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy in advanced pancreatic cancer: time to raise the white flag?
    Welch SA; Moore MJ
    J Clin Oncol; 2007 Jun; 25(16):2159-61. PubMed ID: 17538158
    [No Abstract]   [Full Text] [Related]  

  • 10. Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial.
    Scheithauer W; Schüll B; Ulrich-Pur H; Schmid K; Raderer M; Haider K; Kwasny W; Depisch D; Schneeweiss B; Lang F; Kornek GV
    Ann Oncol; 2003 Jan; 14(1):97-104. PubMed ID: 12488300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic pancreatic cancer response to treatment with cetuximab and gemcitabine plus capecitabine: a case report and review of the literature.
    Li M; Jiang M; Yan X; Wang F; Luo F
    Tumori; 2010; 96(5):764-7. PubMed ID: 21302625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis.
    Fine RL; Fogelman DR; Schreibman SM; Desai M; Sherman W; Strauss J; Guba S; Andrade R; Chabot J
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):167-75. PubMed ID: 17440727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of neoadjuvant therapy in management of pancreatic cancer.
    Li J; Saif MW
    JOP; 2014 Jul; 15(4):354-7. PubMed ID: 25076342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective phase I study of capecitabine and oxaliplatin concurrent with radiation therapy for the treatment of locally advanced pancreatic adenocarcinoma, and retrospective comparison to concurrent 5-fluorouracil/radiation and gemcitabine/radiation.
    Hazard L; Jones K; Shaban A; Anker C; Scaife C; Weis J; Mulvihill S
    J Gastrointest Cancer; 2012 Jun; 43(2):258-66. PubMed ID: 21243531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inoperable pancreatic adenocarcinoma rendered complete remission by high-intensity focused ultrasound concurrent with gemcitabine-capecitabine chemotherapy: case report and topic review.
    Lau PC; Zheng SF; Ng WT; Yu SC
    J Dig Dis; 2012 Jan; 13(1):60-4. PubMed ID: 22188918
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer.
    Esnaola NF; Chaudhary UB; O'Brien P; Garrett-Mayer E; Camp ER; Thomas MB; Cole DJ; Montero AJ; Hoffman BJ; Romagnuolo J; Orwat KP; Marshall DT
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):837-44. PubMed ID: 24606850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic gemcitabine and capecitabine plus intra-arterial epirubicin and cisplatin as second-line chemotherapy in gemcitabine-failure pancreatic cancer.
    Mambrini A; Bassi C; Torri T; Orlandi M; Fiorentini G; Cantore M
    Pancreas; 2011 Aug; 40(6):983-4. PubMed ID: 21562443
    [No Abstract]   [Full Text] [Related]  

  • 18. Sirolimus can reverse resistance to gemcitabine, capecitabine and docetaxel combination therapy in pancreatic cancer.
    Sherman WH
    JOP; 2009 Jul; 10(4):393-5. PubMed ID: 19581741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer.
    Michael M; Price T; Ngan SY; Ganju V; Strickland AH; Muller A; Khamly K; Milner AD; Dilulio J; Matera A; Zalcberg JR; Leong T
    Br J Cancer; 2009 Jan; 100(1):37-43. PubMed ID: 19088724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified GTX as second-line therapy for advanced pancreatic adenocarcinoma.
    Ajouz H; Mukherji D; Haydar A; Yakan AS; Saleh A; Elias E; Temraz S; Faraj W; Khalife M; Shamseddine A
    J Gastrointest Cancer; 2014 Mar; 45(1):109-12. PubMed ID: 24362621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.